Global Biosimilar Markets: Europe vs United States
Europe led the world in biosimilars since 2006 with clear rules and strong adoption. The U.S. lagged due to patents and legal delays - but now, with new FDA rules and cost pressures, it's catching up fast. Here's how the two markets compare today.